Digital health company Prickly Pear Health has increased its pre-seed funding to over $600,000 following a new investment from Emmeline Ventures. The Arizona-based startup focuses on women’s brain health, an area it claims has been historically underserved. Existing investors AZ Venture Capital and Bayless Ventures also participated in the round.
The company uses a combination of artificial intelligence, voice analysis and behavioural data. These tools help women understand the link between hormonal fluctuations and cognitive health. The platform specifically tracks symptoms such as brain fog, memory changes and emotional regulation. These issues often occur during major life transitions including pregnancy, postpartum, perimenopause and menopause.
“I founded Prickly Pear Health to address a critical blind spot in women’s healthcare: how hormonal changes impact brain health. This round reflects a powerful coalition of partners who believe that women deserve better tools to understand what’s happening in their brains during life transitions,” said Imen Maaroufi Clark, Founder and CEO of Prickly Pear Health.
The platform integrates lifestyle information and wearable data with voice patterns to offer personalised well-being insights. While the product was built with women in mind, the company noted that men have also started using the platform. Since the business was founded in 2024, it has reached a milestone of more than 2,000 active users.
Emmeline Ventures, a firm that invests in women’s health outcomes, highlighted the market opportunity at the intersection of data and technology. Azin Radsan van Alebeek, co-founder and general partner at Emmeline Ventures, said: “Prickly Pear Health represents a compelling intersection of technology, data, and an underserved market opportunity.”
The new capital will be used to accelerate the growth of the platform. Prickly Pear Health intends to expand its deployments with mental health practices, beginning in its home state of Arizona. Research suggests that estrogen decline is closely linked to neurological changes, yet few dedicated products exist for these specific cognitive symptoms. The startup aims to fill this gap by providing practical tools for navigating hormonal health.
